Background: "Medical tourism" has gained popularity over the past few decades. This is particularly common with patients seeking elective cosmetic surgery in the developing world. However, the risk of severe and unusual infectious complications appears to be higher than for patients undergoing similar procedures in the United States. Objectives: The authors describe their experience with atypical mycobacterial infections in cosmetic surgical patients returning to the United States postoperatively. Methods: A review of patient medical records presenting with infectious complications after cosmetic surgery between January 2010 and July 2015 was performed. Patients presenting with mycobacterial infections following cosmetic surgery were reviewed in detail. An extensive literature review was performed for rapid-growing mycobacteria (RGM) related to cosmetic procedures.
significant and is often borne by domestic and government insurers.
Patient care is frequently compromised by "lipotourism". First, a lack of recordkeeping and communication makes it hard for domestic physicians to obtain an accurate history. Second, foreign physicians are often reluctant to discuss their treatment. Third, medical equipment and products may be sub-standard or not approved for human surgical use, with little regulation or oversight. Fourth, patients frequently leave their destination to return home before sufficient follow up is completed. Finally, endemic diagnoses are often not seen in routine practice in the United States and a lack of familiarity may delay diagnosis when patients return home.
In April 2004, Centers for Disease Control (CDC) received reports of twelve patients infected with rapid-growing mycobacteria (RGM) after cosmetic surgery procedures in Santo Domingo, Dominican Republic. 9 Definitive testing at CDC determined that all the cases resulted from infection with Mycobacterium abscessus.
Given that other institutions have also noticed mycobacterial infections is patients returning from the developing world, 6 ,9-17 the goal of this study was to evaluate our experience with mycobacterial infections in patients undergoing cosmetic surgery outside of the United States.
METHODS
The study was approved by the Institutional Review Board (IRB Protocol #2015P001933) at Brigham & Women's Hospital (Boston, MA). Medical records of patients who presented to our institution between January 2010 and July 2015 with infectious complications from cosmetic surgery procedures were reviewed. All patients with positive cultures for mycobacteria were included in the present study and underwent a detailed chart review and examination of microbiology and pathology.
Literature Review
An extensive literature review was also performed. A PubMed search was conducted using the keywords "atypical mycobacteria" and "cosmetic surgery" in November 2015. Studies published in language other than English were excluded. Among remaining studies, only those reporting RGM in medical tourists undergoing cosmetic surgical procedures from a developed country that underwent cosmetic surgical procedures in a developing region were included.
RESULTS
During the period studied, three patients presented to our center with postoperative cosmetic surgery complications due to mycobacterial infections -all related to foreign cosmetic procedures. By comparison, no domestic cosmetic surgical patients presented to our institution with mycobacterial infections from over 1200 cosmetic cases. All grew M. abscessus from deep tissue cultures. The mean age of the patients was 36 years (range, 29-44 years) and all were female. Two patients had surgery in Dominican Republic while the third patient underwent their procedures in Mexico. The surgical procedures included silicone implant breast augmentation, mastopexy, liposuction, and abdominoplasty. The demographics and the disease characteristics of all three patients are described in Table 1 . Cultures from all three patients were positive for M. abscessus while tissue acid-fast bacilli stains were positive in two patients. A representative image of M. abscessus from an isolate is shown in Figure 1 . The mycobacteria were resistant to most of the commonly used antibiotics ( Table 2 ). Two of the three patients developed inducible clarithromycin resistance due to erythromycin ribosomal methyltransferase (erm) gene expression. A representative photograph of an infected breast wound at the time of presentation is included in Figure 2A . Prosthetic implants in all infected patients were removed and a 6 to 14 week course of culture-directed antibiotic therapy was provided. The mean time between cosmetic surgery and initial symptoms was 3.7 weeks (range, 3-4 weeks). The mean time between initial symptoms and correct diagnosis of the atypical bacterial infection was 11.7 weeks (range, 5-16 weeks). The delayed diagnosis was generally due to a combination of delayed presentation for medical care, failure to obtain wound cultures, misdiagnosis including the initiation of treatment for typical infections at initial presentation, and time to obtain culture results for atypical bacteria. All infections completely resolved within 12 weeks from diagnosis after the combination of surgical drainage and completion of an appropriate antibiotic regimen.
( Figure 2B ). No recurrent infections have occurred within a mean follow up of 17.66 months (range, 6-30 months).
Literature Review
Seventy studies were selected using the keywords "atypical mycobacteria" and "cosmetic surgery." Only 59 studies were reported in English. Out of those 59 studies, only 10 studies reported RGM in medical tourists from a developed country that underwent cosmetic surgical procedures in a developing region and were included for further review.
DISCUSSION
Medical tourism is a rapidly expanding industry with a projected annual revenue of about $21 billion per year. 18 Cosmetic surgical procedures account for a significant portion of this industry, primarily because these procedures are not covered either by the state-sponsored or typical private health insurance plans. 19 A recent study of the general public in the United Kingdom reported that 97% of 197 respondents would consider going abroad for cosmetic surgery procedures with Eastern Europe and South America being favored destinations. 19 Decreased cost of surgical procedures in developing countries, shorter wait list time, and patients' perceptions of similar outcomes compared to local providers are most critical reasons driving medical tourism. 20 In one study, 60% of the surveyed plastic surgeons reported seeing complications from cosmetic tourists. 21 Of these, 53% of complications were seen as an emergency and two-thirds of these patients required inpatient admission which further increases healthcare costs. 21 Furthermore, only 26% of these cosmetic tourists had an opportunity to follow up with their 
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Aesthetic Surgery Journal 36 (8) operating surgeon. Another study reported an additional cost of £6360 per patient to manage the complications of cosmetic tourism. 22 The goal of this manuscript was to review all the reported case series and case reports of the cosmetic tourists diagnosed with RGM, in addition to reporting the experience at our center. A comprehensive overview of the available literature could provide a better insight vis-à-vis the demographics of the affected patient population, prevalence of the disease with regional specificity, and clinical outcomes of the affected patients. The reported studies comprise of case reports and small case series which highlight the rarity of this disease and are summarized in Table 3. 6,9-17 All the patients described in the literature are young and middleaged females. Abdominoplasty, liposuction, and cosmetic breast surgeries were the most commonly performed procedures. The reported interval between the procedure and the initial presentation was 4 to 7 weeks for majority of the patients. Most of the involved procedures have been reported from the Dominican Republic and other Latin American countries. However, there are also reports of the procedures being performed in Asian countries for patients who are residents in Europe and Australia. 16, 17 Molecular typing using pulsed-field gel electrophoresis and randomly amplified polymorphic DNA polymerase chain reaction confirmed that M. abscessus isolates from 7 out of 12 reported cases by CDC in 2004 were indistinguishable. 9 This suggested that the mycobacteria outbreak stemmed from the same source in all 7 cases. Also, out of 19 cases identified by the Maryland Department of Health and Mental Hygiene, 12 reported undergoing surgery at the same clinic in Dominican Republic. 13 Furuya et al reported that 9 out of the 19 patients in their study underwent surgery at the same clinic and 8 of these 9 patients were related by molecular typing. 6 These data support the belief that these infections often stem from the same initial source.
M. abscessus belongs to the group of RGM which also includes M. fortuitum and M. chelonae. 23 They grow within one week, compared with other species of mycobacteria which take up to 6 weeks to grow in culture. M. abscessus is ubiquitous in the environment and has been isolated from municipal and well water, soil, and dust. 23 It has been associated with a variety of nosocomial outbreaks following cosmetic procedures and non-cosmetic procedures such as podiatric surgery, hemodialysis, and myringotomy. 6, [9] [10] [11] [12] [13] [14] [15] [16] [17] [24] [25] [26] In the largest published series of 63 patients with skin and soft tissue infection due to RGM over 17 years, most of the patients with single lesion had a history of trauma or a medical procedure at the subsequent site of infection. 27 The median time between symptom onset and microbiological diagnosis was 86 days. Forty-five patients were treated with total of 102 courses of antimicrobial agents, with combination therapy prescribed in 80% of these cases. The median duration of parenteral antimicrobial agents was 25 days while the median duration of oral antimicrobial agents was 127 days. Specific information about sequential usage of parenteral antibiotics followed by oral antibiotics was not available in this study. Surgery was performed in 37 (59%) patients out of whom 9 patients were treated with surgery alone. 27 There has only been a single study describing the outbreak of RGM infection following liposuction in the United States 28 as compared to multiple studies described in the developing world. 8 patients with M. abscessus. All of these 8 patients had undergone cosmetic surgery in the Dominican Republic. Over the same time period, there were no reported cases of M. abscessus infection complicating >230,000 surgical procedures performed at this medical center or >60,000 performed at Baystate Medical Center (Springfield, MA). 6 This might provide indirect evidence of increased M. abscessus complication rates in Dominican Republic as compared to the United States but there has been no definitive study comparing all data in all patients from both countries, and the logistics of doing so make this near impossible.
Ineffective sterilization of surgical instruments or injectable solutions have been hypothesized as a contributing factor in numerous mycobacterial outbreaks. Inexpensive and low-level chemical methods of sterilization such as usage of quaternary ammonium solutions have been implicated in the outbreak of mycobacterial infection. 29, 30 Torres et al reported 7 cases of culture-confirmed RGM wound 
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Aesthetic Surgery Journal 36 (8) infections following liposuction. In these patients, liposuction cannulae were cleaned with tap water and soap followed by low-level disinfection with a commercial quaternary ammonium solution. 29 Following the report of this outbreak, two of the affected surgical facilities switched to high-level disinfection such as ethylene oxide gas sterilization, and no further cases of RGM infections have been reported from these facilities. 29 Because of their minimal effectiveness against mycobacteria, commercial quaternary ammonium solutions are not included in current disinfection recommendations in the United States. 31, 32 In another study, isolates from the 12 patients with culture-confirmed RGM infection and an environmental isolate collected from the faucet in a physician's office differed by only 1 to 2 restriction bands, which raises the possibility of RGM outbreak transmission from the potable water supply. 28 Reuse of liposuction cannulas after rinsing with tap water followed by inadequate disinfection, an inappropriate medical environment, and lack of knowledge pertaining to infection control among the medical team members were identified as key factors leading to such infectious complications. 28 In a recent study, nontuberculous mycobacteria (NTM) were detected in 78% of potable water sources collected from 25 states across the United States, of which M. abscessus was reported in 12% of the samples. 33 The study also observed statistically significantly higher levels of NTM in chloraminated water than in chlorinated water. Meticulous attention regarding the sterilization techniques is critical to the prevention of the RGM infection outbreaks.
Since RGM infections do not require mandatory reporting to public health departments, the actual incidence of this infection might be considerably higher than reported. Failure of the wounds to heal after conventional treatment should raise concern for atypical infections. It should be noted that the incubation period of RGM infections could vary from weeks to months and the diagnosis should not be discounted based on delayed presentation. For accurate diagnosis, both wound drainage and tissue biopsy should be sent for acid-fast staining, mycobacterial culture, and routine surgical pathology. The RGM will grow on blood agar, MacConkey agar, and Lowenstein-Jensen medium ( primarily used for mycobacteria) in about 7 days. The culture sensitivity may be enhanced by also incubating the specimen at 28°C to 30°C (besides the standard 37°C) since some strains of RGM grow at lower temperatures. 34 Similar to previous reports of RGM infections, our patients predominantly exhibited erythema, tenderness, and serous drainage from surgical wounds. Failure of antibiotics against common pathogens in our patient population (such as Staphylococcus and Streptococcus) and a lack of bacterial growth on routine cultures raised concern for atypical infection. Treatment of RGM infections depends on the clinical manifestation and antimicrobial sensitivity. A combination of surgical drainage, removal of prosthetic material, and a prolonged course of culture-directed antibiotic therapy are the appropriate initial treatments. [9] [10] [11] [12] [13] [14] [15] [16] [17] Extensive drug resistance is very common in RGM wound infections and optimal therapeutic antibiotic regimens have not been established in controlled studies. Severe infections initially require a multi-week course of intravenous antibiotics, often cefoxitin and amikacin, which covers majority of RGM isolates. 34 While most RGM demonstrate susceptibility of cefoxitin, its poor availability in the United States limits its use in this setting. Amikacin and imipenem are often employed as initial empiric intravenous therapy in such scenarios, in combination with oral clarithromycin or azithromycin while awaiting susceptibility testing. Tobramycin has good activity against M. chelonae and tigecycline, and clofazamine may be useful in the treatment of cases that are resistant to amikacin, imipenem, or both. 35, 36 Initial parenteral therapy is followed by an oral regimen with a macrolide backbone such as clarithromycin. Oral linezolid is also frequently used as part of combination therapy for RGM, though long term use may be limited by gastro-intestinal tolerability, pancytopenia, and peripheral neuropathy. Total duration of therapy is dependent on severity of infection and clinical response, but may span 2 to 12 months. 6 Clarithromycin can be used alone or as a combination therapy but no prospective trials have compared these options. The single clinical trial using clarithromycin monotherapy reported only 1 case of acquired clarithromycin resistance in a non-compliant patient who prematurely discontinued therapy. 37 When used as a singledrug therapy, Wallace et al have recommended daily usage of clarithromycin for at least 4.5 months. 38 However, both M. abscessus and M. fortuitum have been found to possess erythromycin ribosomal methyltransferase (erm) genes that modify the binding sites for macrolides and confer inducible antibiotic resistance. 38, 39 This results in "susceptible" noted at day 3 of incubation and "resistance" by incubation period of 14 days. 40 Clarithromycin resistance has been described in the clinical isolates of M. abscessus complex 41 and inducible clarithromycin resistance due to erm gene was seen in 2 out of 3 patients in our study. With this knowledge, it would be prudent to use combination therapy when transitioning to oral antibiotic therapy. 40 A limitation of our study stems from the small sample size and a single institution experience. Our study reports only three medical tourists with RGM wound infections following cosmetic surgery procedures in developing countries. However, the limited number of cases in the literature highlights the rarity of this diagnosis. With the increased frequency of medical tourism and low-cost cosmetic procedures, the suspicion of RGM needs to be entertained for any infection unresponsive to therapy, particularly when the surgery was performed in a developing country.
CONCLUSIONS
Atypical mycobacterial infections appear to be more common in medical tourists undergoing cosmetic surgery procedures in developing countries. Such an increased incidence might be attributed to endemic infections and inadequate sterilization of surgical instruments. Management is generally delayed by the lack of clinical suspicion resulting in a failure to order mycobacteria-specific cultures. Consulting physicians, including plastic surgeons, should have a low threshold to consider atypical etiologies in such scenarios allowing rapid diagnosis and appropriate treatment.
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